We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBDS
1226
DELISTED
Solo Brands Inc
SBDS
| $2.96M | 0.01% |
10,308
+3,241
| +46% | +$623K |
|
1227
Alphatec Holdings
ATEC
$1.43B
| $2.95M | 0.01% |
+189,250
| New | +$2.68M |
|
|
MASI
1228
DELISTED
Masimo
MASI
| $2.94M | 0.01% |
15,932
-38,690
| -71% | -$6.53M |
|
|
TIXT
1229
DELISTED
TELUS International
TIXT
| $2.93M | 0.01% |
145,020
-160,640
| -53% | -$3.47M |
|
1230
CALL
Wells Fargo
WFC
$263B
| $2.92M | 0.01% |
78,200
-474,300
| -86% | -$20.7M |
|
|
UNIT
1231
Uniti Group
UNIT
$2.53B
| $2.92M | 0.01% |
+821,174
| New | +$4.36M |
|
1232
Omnicell
OMCL
$1.96B
| $2.91M | 0.01% |
+49,635
| New | +$2.74M |
|
|
FITB
1233
PUT
Fifth Third Bancorp
FITB
$52.4B
| $2.89M | 0.01% |
+108,500
| New | +$3.61M |
|
|
OCAXW
1234
CALL
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
| $2.85M | 0.01% |
274,997
| – | – |
|
1235
8x8 Inc
EGHT
$271M
| $2.85M | 0.01% |
683,854
+286,107
| +72% | +$1.43M |
|
1236
VanEck Semiconductor ETF
SMH
$63.8B
| $2.85M | 0.01% |
21,662
-9,546
| -31% | -$1.14M |
|
1237
Applovin
APP
$140B
| $2.85M | 0.01% |
180,781
+155,691
| +621% | +$2.04M |
|
|
ESTE
1238
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $2.84M | 0.01% |
+218,330
| New | +$2.93M |
|
1239
CVB Financial
CVBF
$4.02B
| $2.83M | 0.01% |
+169,919
| New | +$3.87M |
|
|
CBRGW
1240
CALL
DELISTED
Chain Bridge I Warrants
CBRGW
| $2.83M | 0.01% |
270,399
| – | – |
|
1241
Elbit Systems
ESLT
$38.4B
| $2.83M | 0.01% |
16,640
+12,555
| +307% | +$2.14M |
|
1242
Simulations Plus
SLP
$371M
| $2.83M | 0.01% |
64,420
+33,937
| +111% | +$1.36M |
|
1243
Concentrix
CNXC
$1.55B
| $2.83M | 0.01% |
23,261
-88,980
| -79% | -$12.1M |
|
|
WW
1244
DELISTED
WW International
WW
| $2.83M | 0.01% |
+685,691
| New | +$3M |
|
|
AVDL
1245
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.82M | 0.01% |
+307,875
| New | +$2.53M |
|
1246
CarGurus
CARG
$3.28B
| $2.82M | 0.01% |
150,880
-32,777
| -18% | -$558K |
|
1247
Energy Recovery
ERII
$433M
| $2.81M | 0.01% |
121,934
+102,452
| +526% | +$2.25M |
|
|
ARBGW
1248
CALL
DELISTED
Aequi Acquisition Corp warrants
ARBGW
| $2.81M | 0.01% |
276,661
| – | – |
|
1249
Quest Diagnostics
DGX
$26B
| $2.81M | 0.01% |
19,827
-90,395
| -82% | -$12.9M |
|
|
1250
Qualcomm
QCOM
$172B
| $2.8M | 0.01% |
21,979
-1,830,506
| -99% | -$228M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.